Xiujuan Qu

Academic / Other · 2 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresect Urothelial Carcinoma, Biliary Tract Cancer, HER2	Phase 2	2025-07-15
Active Not Recruiting	Plasma Multi - Omics Detection for Evaluating Efficacy and Recurrence Risk in Oligometastatic Colorectal Cance Colorectal Cancer	N/A	2025-03-20